On Invalid Date, Achilles Therapeutics (NASDAQ: ACHL) reported Q1 2023 earnings per share (EPS) of -$0.44, up 2.22% year over year. Total Achilles Therapeutics earnings for the quarter were -$17.51 million. In the same quarter last year, Achilles Therapeutics's earnings per share (EPS) was -$0.45.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.